• Accenture Plc: Wells Fargo upgrades to overweight from market weight with a target price of USD 275.
  • Alnylam Pharmaceuticals, Inc.: Freedom Broker upgrades to buy from hold and reduces the target price from USD 470 to USD 410.
  • Bath & Body Works, Inc.: Citi downgrades to neutral from buy and raises the target price from USD 21 to USD 25.
  • Conocophillips: Roth Capital Partners downgrades to neutral from buy with a target price of USD 112.
  • Dollar Tree, Inc.: Rothschild & Co Redburn upgrades to buy from neutral with a price target raised from USD 75 to USD 165.
  • Jack Henry & Associates, Inc.: Wells Fargo upgrades to overweight from equalweight and raises the target price from USD 181 to USD 196.
  • Marsh & Mclennan Companies: Raymond James upgrades to strong buy from outperform and reduces the target price from USD 240 to USD 225.
  • Southwest Airlines Co.: UBS upgrades to buy from neutral and raises the target price from USD 51 to USD 73.
  • Truist Financial Corporation: Morgan Stanley upgrades to overweight from market weight with a price target raised from USD 56 to USD 69.
  • Upstart Holdings, Inc.: Compass Point Research & Trading upgrades to neutral from sell with a price target raised from USD 20 to USD 30.
  • Veeva Systems Inc.: Morgan Stanley upgrades to market weight from underweight and reduces the target price from USD 222 to USD 205.
  • Warner Bros. Discovery, Inc.: Rothschild & Co Redburn downgrades to neutral from buy and raises the target price from USD 28 to USD 31.
  • Applied Materials, Inc.: DZ Bank AG Research maintains its hold recommendation and raises the target price from USD 205 to USD 340.
  • Coinbase Global, Inc.: Mizuho Securities maintains its neutral recommendation and reduces the target price from USD 280 to USD 170.
  • Draftkings Inc.: JP Morgan maintains its overweight recommendation and reduces the target price from USD 41 to USD 32.
  • Iqvia Holdings Inc.: TD Cowen maintains its hold recommendation and reduces the target price from USD 245 to USD 174.
  • Lumentum Holdings Inc.: Mizuho Securities maintains its outperform recommendation and raises the target price from USD 525 to USD 645.
  • Moderna, Inc.: Bernstein maintains its market perform recommendation and raises the target price from USD 35 to USD 45.
  • Robinhood Markets, Inc.: Mizuho Securities maintains its outperform rating and reduces the target price from USD 172 to USD 135.
  • Salesforce, Inc.: UBS maintains its neutral recommendation and reduces the target price from USD 260 to USD 200.
  • Walmart Inc.: Rothschild & Co Redburn maintains its buy recommendation and raises the target price from USD 110 to USD 150.
  • Workday Inc.: BMO Capital Markets maintains its outperform recommendation and reduces the target price from USD 285 to USD 204.
  • Yeti Holdings, Inc.: Piper Sandler & Co maintains its overweight recommendation and raises the target price from USD 43 to USD 54.